AU7638498A - Cyanoguanidines as cell proliferation inhibitors - Google Patents

Cyanoguanidines as cell proliferation inhibitors

Info

Publication number
AU7638498A
AU7638498A AU76384/98A AU7638498A AU7638498A AU 7638498 A AU7638498 A AU 7638498A AU 76384/98 A AU76384/98 A AU 76384/98A AU 7638498 A AU7638498 A AU 7638498A AU 7638498 A AU7638498 A AU 7638498A
Authority
AU
Australia
Prior art keywords
cyanoguanidines
cell proliferation
proliferation inhibitors
inhibitors
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76384/98A
Inventor
Erik Rytter Ottosen
Charlotte Schou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Publication of AU7638498A publication Critical patent/AU7638498A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
AU76384/98A 1997-05-29 1998-05-15 Cyanoguanidines as cell proliferation inhibitors Abandoned AU7638498A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9711122 1997-05-29
GBGB9711122.3A GB9711122D0 (en) 1997-05-29 1997-05-29 Novel cyanoguanidines
PCT/DK1998/000194 WO1998054142A1 (en) 1997-05-29 1998-05-15 Cyanoguanidines as cell proliferation inhibitors

Publications (1)

Publication Number Publication Date
AU7638498A true AU7638498A (en) 1998-12-30

Family

ID=10813252

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76384/98A Abandoned AU7638498A (en) 1997-05-29 1998-05-15 Cyanoguanidines as cell proliferation inhibitors

Country Status (3)

Country Link
AU (1) AU7638498A (en)
GB (1) GB9711122D0 (en)
WO (1) WO1998054142A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061561A1 (en) 1999-04-09 2000-10-19 Shionogi Bioresearch Corp. Cyanoguanidine compounds
MXPA03010669A (en) 2001-05-24 2004-07-01 Leo Pharma As Novel pyridyl cyanoguanidine compounds.
WO2002094265A1 (en) * 2001-05-24 2002-11-28 Leo Pharma A/S A method of modulating nf-$g(k)b activity
US6642215B2 (en) 2001-05-24 2003-11-04 Leo Pharma A/S Method of modulating NF-kB activity
US20030045515A1 (en) * 2001-05-24 2003-03-06 Lise Binderup Combination medicament for treatment of neoplastic diseases
US7253193B2 (en) 2002-05-17 2007-08-07 Leo Pharma A/S Cyanoguanidine prodrugs
GB0417802D0 (en) * 2004-08-10 2004-09-15 Novartis Ag Organic compounds
ES2572777T3 (en) 2004-12-22 2016-06-02 Leo Pharma A/S Novel cyanoguanidine compounds
AU2010257504B2 (en) * 2009-06-09 2015-04-09 Onxeo Dk, Branch Of Onxeo S.A., France Pyridinyl derivatives as inhibitors of enzyme nicotinamide phosphoribosyltransferase
US8912184B1 (en) 2010-03-01 2014-12-16 Alzheimer's Institute Of America, Inc. Therapeutic and diagnostic methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219472D0 (en) * 1992-09-15 1992-10-28 Leo Pharm Prod Ltd Chemical compounds

Also Published As

Publication number Publication date
WO1998054142A1 (en) 1998-12-03
GB9711122D0 (en) 1997-07-23

Similar Documents

Publication Publication Date Title
AU6477498A (en) Scale inhibitors
AU8054298A (en) Primal tracking
AU1301697A (en) Tyrosin-derivate as alpha-v-integrin inhibitors
AU5170900A (en) Cell proliferation inhibitors
AU6411698A (en) Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
AU4956297A (en) Raf kinase inhibitors
AU1725099A (en) Devices for cloaking transplanted cells
AU5991699A (en) Quinolizinones as integrin inhibitors
AU2548699A (en) Cell death inhibitors
AU3769097A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
AU4296397A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
PL337331A1 (en) Cyanoguanidines as cell proliferation inhibitors
AU5335798A (en) Stomatic composition
AU8747498A (en) Food-preservative composition
HK1039116A1 (en) Cyanoguanidines as cell proliferation inhibitors
AU2832399A (en) B cell inhibitors
AU6687900A (en) Phenoxy fluoropyrimidines
AU5203698A (en) Fluid-treatment assemblies
AU7638498A (en) Cyanoguanidines as cell proliferation inhibitors
AU4697600A (en) Methods for increasing t cell proliferation
AU1684400A (en) Substituted benzylamines
AU3235100A (en) Prothease inhibitors
AU8121998A (en) Composition
PL337031A1 (en) Cyanoguanidines as inhibitors of cell proliferation
AU1013997A (en) Amylase inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase